glp-1 agonists long term side effects The expanding role of receptor agonists: a narrative review of current evidence and future directions glp-1 long-term side effects cancer
Description
The risks of diarrhea was significantly higher for JNJ-64565111, Exenatide, Liraglutide, Orforglipron and Tirzepatide than for placebo, with Orforglipron having an RR of 5.56
Market leader Lilly is developing its own amylin analogue called eloralintide that's already in Phase 3 trials
Orforglipron is the active ingredient
Ward et al
J Clin Invest 113, 635645 (2004)
They achieve this by signaling a cascade consisting of cAMP and protein kinase A and the closure of K ATP gates, induced by PKA cycle, marks the initiation of glucose dependent insulin secretion into the bloodstream (51)
